Exelixis Inc (EXEL)
22.16
+0.26
(+1.16%)
USD |
NASDAQ |
May 07, 16:00
22.16
0.00 (0.00%)
After-Hours: 20:00
Exelixis 1 Year Total Returns (Daily): 12.45% for May 6, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 06, 2024 | 12.45% |
| May 03, 2024 | 14.00% |
| May 02, 2024 | 17.47% |
| May 01, 2024 | 16.44% |
| April 30, 2024 | 28.20% |
| April 29, 2024 | 29.67% |
| April 26, 2024 | 28.46% |
| April 25, 2024 | 24.83% |
| April 24, 2024 | 26.12% |
| April 23, 2024 | 22.51% |
| April 22, 2024 | 20.31% |
| April 19, 2024 | 17.54% |
| April 18, 2024 | 17.50% |
| April 17, 2024 | 15.80% |
| April 16, 2024 | 17.27% |
| April 15, 2024 | 16.65% |
| April 12, 2024 | 17.03% |
| April 11, 2024 | 12.80% |
| April 10, 2024 | 17.75% |
| April 09, 2024 | 15.82% |
| April 08, 2024 | 14.01% |
| April 05, 2024 | 16.34% |
| April 04, 2024 | 20.15% |
| April 03, 2024 | 21.61% |
| April 02, 2024 | 20.25% |
| Date | Value |
|---|---|
| April 01, 2024 | 22.00% |
| March 28, 2024 | 26.43% |
| March 27, 2024 | 27.87% |
| March 26, 2024 | 27.76% |
| March 25, 2024 | 28.25% |
| March 22, 2024 | 29.87% |
| March 21, 2024 | 28.81% |
| March 20, 2024 | 29.35% |
| March 19, 2024 | 33.73% |
| March 18, 2024 | 32.02% |
| March 15, 2024 | 29.10% |
| March 14, 2024 | 29.42% |
| March 13, 2024 | 37.24% |
| March 12, 2024 | 36.03% |
| March 11, 2024 | 34.65% |
| March 08, 2024 | 35.76% |
| March 07, 2024 | 34.04% |
| March 06, 2024 | 35.88% |
| March 05, 2024 | 29.80% |
| March 04, 2024 | 31.49% |
| March 01, 2024 | 27.30% |
| February 29, 2024 | 28.22% |
| February 28, 2024 | 28.28% |
| February 27, 2024 | 24.41% |
| February 26, 2024 | 28.20% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-41.05%
Minimum
Mar 16 2020
63.00%
Maximum
Mar 16 2021
3.06%
Average
-1.06%
Median
1 Year Total Returns (Daily) Benchmarks
| Regeneron Pharmaceuticals Inc | 25.79% |
| Johnson & Johnson | -5.87% |
| Merck & Co Inc | 11.37% |
| Pfizer Inc | -23.01% |
| Legend Biotech Corp | -32.44% |